TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination.

导出 OA

翻译打印收藏纠错

作者： Cheng-Fei,Jiang ^[1] ; Yun-Xia,Xie ^[2] ; Ying-Chen,Qian ^[1] ; Min,Wang ^[1] ; Ling-Zhi,Liu ^[3] ; Yong-Qian,Shu ^[4] ; Xiao-Ming,Bai ^[5] ; Bing-Hua,Jiang ^[6]

作者单位： Department of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, China. ^[1] The Academy of Medical Sciences, Zhengzhou University, Zhengzhou, 450052, Henan, China. ^[2] Department of Medical Oncology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA, 19107, USA. ^[3] Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, China. ^[4] Department of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, China. baixiaoming@njmu.edu.cn. ^[5] Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA, 19107, USA. baixiaoming@njmu.edu.cn. ^[6] Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA, 19107, USA. binghua.jiang@jefferson.edu. ^[7]

关键词 Breast cancer Doxorubicin resistance KIF2C PKM2 TBX15 miR-152

DOI 10.1186/s12935-021-02235-w

PMID 34663310

发布时间 2021-10-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交